Evidence Unveiled: Bridging Data Analytics and Evidence for Better Patient Outcomes
We are thrilled to welcome you to the 7th Annual Real-World Evidence and Life Science Analytics Conference at Boston 2024, a premier gathering of thought leaders, industry experts, and innovators at the forefront of revolutionizing healthcare through data-driven insights. Set against the backdrop of advancements in real-world evidence, this conference promises an enriching experience for professionals in life sciences, healthcare, and analytics.
The 7th Annual Real-World Evidence and Life Science Analytics Conference is not just an event; it's an opportunity to be part of the conversation shaping the future of healthcare. Join us for an inspiring and collaborative experience as we explore ways to bridge insights to impact in the dynamic world of real-world evidence.
WHAT TO EXPECT
Key Highlights:
- Gain insights into regulatory perspectives on data quality and standards, Integration of RWE into Clinical Trials
- Explore the strategic utilization of Real-World Evidence (RWE) to enhance market access.
- Regulatory Landscape for Medical Devices, Post-Market Surveillance and Safety Monitoring
- Uncover the expanded realm of RWE's influence on digital health, Patient-Centric Approaches in Device Research
- Examine the synergy between Real-World Data and Advanced Analytics, Economic impact evaluations using real-world evidence.
- Epidemiological Insights using Real World Evidence
Why Attend?
- Latest insights and updates on trends
- Networking opportunities
- Professional Development
- Interdisciplinary Learning
- Insights into current regulatory perspectives
- Access to Thought Leaders
- Showcasing innovative technologies
Agenda
Day 1
Evidence Synergy: Bridging Outcomes, Access, and Analytics for Real-World Impact
Registration - 08:15 - 08:50
Welcome note - 08:50 - 08:55
Opening remarks by the Chairperson - 08:55 - 09:00
Integration of RWE into Clinical Trials
Keynote Presentation - Strategies for incorporating real-world data into traditional clinical trial designs - 09:00 - 09:30
Health system adoption of evidence from clinical trials and real-world studies - 09:30 - 10:00
Slot Reserved for Sponsors (Gold/Platinum) - Forian - 10:00 - 10:30
Morning Refreshments and Poster Presentation - One-to-One Networking Meeting - 10:30 - 11:10
Patient-Centered Outcomes Research
Using Patient-Generated Health Data for more Nuanced Clinical Outcomes for Medical Product Development
Nancy Dreyer, Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill - 11:10 - 11:40
Slot Reserved for Sponsors (Gold/Silver) - Prognos health - 11:40 - 12:10
Measuring what you want to manage: new approaches to measure patient diversity in RWE.
Adrian Kielhorn, Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc - 12:10 - 12:40
Slot Reserved for Sponsors (Silver) - OM1/Komodo - 12:40 - 13:10
Lunch and Poster Presentation - One-to-One Networking - 13:10 - 14:10
Health Economics and Market Access
Economic impact evaluations using real-world evidence. - 14:10 - 14:40
Understanding the data leader’s role in establishing the value of RWD
Lou Brooks, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences
Eric Fontana, Vice President, Client Solutions, Real-World Data, Optum Life Sciences - 14:40 - 15:15
Demonstrating value and reimbursement strategies. - 15:15 - 15:55
Evening Refreshments - One-to-One Networking - 15:55 - 16:35
AI and ML Applications in Life Sciences RWE
Slot Reserved for Sponsors - 16:35 - 17:05
AI and ML in life sciences: Buzz words? or Reason for Optimism!
Ravi Iyer
Ravi Iyer, Sr. Director,Head Real World Evidence Strategy,GHEOR, Teva Pharmaceuticals - 17:05 - 17:35
Slot Reserved for Sponsors - 17:35 - 18:05
Predictive analytics for patient recruitment, enrollment, and retention. - 18:05 - 18:35
Closing remarks by the Chairperson - 18:35 - 18:35
End of Conference - Drinks and Reception - 18:35 - 18:35
Day 2
InnovateHealth: Precision Solutions in Evidence, Medicine, and Epidemiology
Registration - 08:15 - 08:50
Welcome note - 08:50 - 08:55
Opening remarks by the Chairperson - 08:55 - 09:00
Healthcare Innovation and Technology
Blockchain and other technologies for data integrity and transparency. - 09:00 - 09:30
Impact of technological advancements on patient outcomes - 09:30 - 10:00
Slot Reserved for Sponsors (Gold/Platinum) - 10:00 - 10:30
Morning Refreshments and Poster Presentation - One-to-One Networking Meeting - 10:30 - 11:10
Precision Medicine and Personalized Healthcare
Genomic data integration in patient outcomes research. - 11:10 - 11:40
Slot Reserved for Sponsors (Silver) - 11:40 - 12:10
Tailoring treatments based on real-world evidence. - 12:10 - 12:40
Slot Reserved for Sponsors - 12:40 - 13:10
Lunch and Poster Presentation - One-to-One Networking - 13:10 - 14:10
Epidemiological Insights from Real-World Evidence
Large-scale epidemiological studies using real-world evidence. - 14:10 - 14:40
Population-level insights for public health decision-making. - 14:40 - 15:10
Closing remarks by the Chairperson - 15:10 - 15:10
----End of Conference--- - 15:10 - 15:10
Speakers
Megan Sutton
Senior Medical Director, Clinical Development and Real-world Evidence, Lexeo Therapeutics
Adrian Kielhorn
Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc
Amit Kulkarni
Head of Health Economic Modeling and Decision Sciences, Otsuka Pharmaceutical Companies
Nancy Dreyer
Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill
Ravi Iyer
Sr. Director, Head Real World Evidence Strategy, GHEOR, Teva Pharmaceuticals
Prasun Mishra
Co-Founder, Precision BioPharma
Lou Brooks
Senior Vice President, Real-World Data and Analytics, Optum Life Sciences
Eric Fontana
Vice President, Client Solutions, Real-World Data, Optum Life Sciences
Who Should Attend
From pharmaceutical and Biopharmaceutical companies
Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-
- Real-World Evidence
- Real-World Data
- Data Analytics
- Health Economics & Outcomes Research- HEOR
- Market Access/Value Access
- Policy
- Clinical Development & research
- Clinical trial
- Centre for Observational and Real-World Evidence
- Epidemiology
- Oncology-RWE
- Pricing and Reimbursement
- Medical Affairs
- Pharmacovigilance
- Life Science Analytics
- Big data
- Data Science
- Bio-Statistics
- Consumer Healthcare
Others
Payers, Regulators, Research Institutes, and Innovation Centre
Location
ADDRESS
Boston, MA
United States
Venue to be announced shortly.
